In early trading on Wednesday, shares of ON Semiconductor topped the list of the day's best performing components of the S&P 500 index, trading up 9.0%. Year to date, ON Semiconductor registers a 109.5% gain. And the worst performing S&P 500 component thus far on the d
In early trading on Wednesday, shares of ON Semiconductor topped the list of the day's best performing components of the S&P 500 index, trading up 9.0%. Year to date, ON Semiconductor registers a 109.5% gain. And the worst performing S&P 500 component thus far on the d
Industry-Leading Event Shares Early Details, Including Keynotes from Cisco, Russell Reynolds Associates, and MicrosoftWEST PALM BEACH, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- The leading event for forward-thinking HR leaders, HR Tech, returns to Mandalay Bay in Las Vegas this October 20 – 22, ready to unite the community, showcase the latest strategies and solutions, and move the industry conversat...
Industry-Leading Event Shares Early Details, Including Keynotes from Cisco, Russell Reynolds Associates, and MicrosoftWEST PALM BEACH, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- The leading event for forward-thinking HR leaders, HR Tech, returns to Mandalay Bay in Las Vegas this October 20 – 22, ready to unite the community, showcase the latest strategies and solutions, and move the industry conversation forward, from navigating change to delivering real transformation. With the rapidly evolving nat
Palantir Technologies delivered a first quarter marked by accelerating demand for its operational AI platform, particularly in the United States. Management credited broad-based adoption of its AI-enabled solutions across both commercial and government segments as the primary driver of performance, with U.S. revenue growth exceeding 100% year-over-year for the first time since its public debut. CE...
Palantir Technologies delivered a first quarter marked by accelerating demand for its operational AI platform, particularly in the United States. Management credited broad-based adoption of its AI-enabled solutions across both commercial and government segments as the primary driver of performance, with U.S. revenue growth exceeding 100% year-over-year for the first time since its public debut. CEO Alexander Karp highlighted the company's ability to transform traditional workflows and deliver me
Mohamad Faizal Bin Ramli/iStock via Getty Images Meta stock: option market underestimates true volatility after FQ1 earnings I last covered Meta Platforms ( META ) on Mar 27 with an article entitled " Meta Platforms: Lean Into The Fear As P/Cash Drops To 10x”. The article focused on the layoff plans announced at that time and rated the stock as a buy. Since then, a few new catalysts have emerged a...
Mohamad Faizal Bin Ramli/iStock via Getty Images Meta stock: option market underestimates true volatility after FQ1 earnings I last covered Meta Platforms ( META ) on Mar 27 with an article entitled " Meta Platforms: Lean Into The Fear As P/Cash Drops To 10x”. The article focused on the layoff plans announced at that time and rated the stock as a buy. Since then, a few new catalysts have emerged and promoted this follow-up. More specifically, I will focus on two of the catalysts: the operating updates the company updated in its FQ1 2026 earnings report (ER) and also the changes in the option market. These changes have led me to conclude that A) META’s current IV (implied volatility) represents an underestimate of the true volatility, and B) thus provides attractive pricing for buyers for option buyers. Let me start with a recap of the ER to better contextualize the rest of the discussion. The ER was released on April 29. Overall, the company reported a strong quarter with earnings beating consensus on both lines as seen in the snapshot below. In particular, topline continued its growth with double-digit rates (+33% YOY). Yet, the higher capex outlook for FY 2026 weighed on market sentiment and share prices suffered some downward volatilities afterwards. The volatilities have quieted down significantly since then, probably too quiet judging by its IV as detailed next. Seeking Alpha META’s implied volatility (IV) is below average The current IV underling META shares have become relatively low. More specifically, the following statistics were taken from MarketChameleon and reveal that META’s current IV of 30.1 is noticeably below its historical norm. To wit, the current reading is more than 10% below the 52-week average of 33.5. In terms of percentile rank, the current reading is in the 39% percentile. The current IV is also more than 18% below its 20-day moving average of 36.9, indicating it is trending lower. META IV These statistics led me to see a gap between the p...
Mohamad Faizal Bin Ramli/iStock via Getty Images Meta stock: option market underestimates true volatility after FQ1 earnings I last covered Meta Platforms ( META ) on Mar 27 with an article entitled " Meta Platforms: Lean Into The Fear As P/Cash Drops To 10x”. The article focused on the layoff plans announced at that time and rated the stock as a buy. Since then, a few new catalysts have emerged a...
Mohamad Faizal Bin Ramli/iStock via Getty Images Meta stock: option market underestimates true volatility after FQ1 earnings I last covered Meta Platforms ( META ) on Mar 27 with an article entitled " Meta Platforms: Lean Into The Fear As P/Cash Drops To 10x”. The article focused on the layoff plans announced at that time and rated the stock as a buy. Since then, a few new catalysts have emerged and promoted this follow-up. More specifically, I will focus on two of the catalysts: the operating updates the company updated in its FQ1 2026 earnings report (ER) and also the changes in the option market. These changes have led me to conclude that A) META’s current IV (implied volatility) represents an underestimate of the true volatility, and B) thus provides attractive pricing for buyers for option buyers. Let me start with a recap of the ER to better contextualize the rest of the discussion. The ER was released on April 29. Overall, the company reported a strong quarter with earnings beating consensus on both lines as seen in the snapshot below. In particular, topline continued its growth with double-digit rates (+33% YOY). Yet, the higher capex outlook for FY 2026 weighed on market sentiment and share prices suffered some downward volatilities afterwards. The volatilities have quieted down significantly since then, probably too quiet judging by its IV as detailed next. Seeking Alpha META’s implied volatility (IV) is below average The current IV underling META shares have become relatively low. More specifically, the following statistics were taken from MarketChameleon and reveal that META’s current IV of 30.1 is noticeably below its historical norm. To wit, the current reading is more than 10% below the 52-week average of 33.5. In terms of percentile rank, the current reading is in the 39% percentile. The current IV is also more than 18% below its 20-day moving average of 36.9, indicating it is trending lower. META IV These statistics led me to see a gap between the p...
Gilnature/iStock via Getty Images Thesis Summary Nebius Group N.V. ( NBIS ) just delivered another major win, and the stock is up 15% pre-market . Revenue surged 684% YoY, while ARR climbed to $1.9 billion, and adjusted EBITDA turned strongly positive. However, what makes me the most bullish is what Nebius has in store for the future. Nebius is moving up the stack into inference, agentic AI, orche...
Gilnature/iStock via Getty Images Thesis Summary Nebius Group N.V. ( NBIS ) just delivered another major win, and the stock is up 15% pre-market . Revenue surged 684% YoY, while ARR climbed to $1.9 billion, and adjusted EBITDA turned strongly positive. However, what makes me the most bullish is what Nebius has in store for the future. Nebius is moving up the stack into inference, agentic AI, orchestration, and production-scale deployment. This is obvious when we look at the acquisitions of Eigen AI, Tavily, and Clarifai. The company is moving from a simple “GPU renter” to an AI giant, ready to take a much bigger slice of the pie. Q1 Overview Nebius delivered record results , much as the market expected. NBIS Overview (Investor Presentation) Revenue increased 684% YoY to $399 million, though they missed estimates marginally. ARR is up 54% sequentially, showing that, indeed, demand continues to accelerate. The company also raised its contracted power guidance and broke ground on its new Missouri factory today . What may have surprised a lot of people is that Nebius generated $129.5 million in adjusted EBITDA, versus a loss of $53.7 million a year ago. While this number does discount depreciation, investors can no longer deny that Nebius is generating real cash. NBIS Q1 Financial highlights (Investor slides) The company still expects to bring in over $3B in revenue in 2026 while also achieving margins of 40%. And with $9.3 billion in cash, Nebius is sitting pretty right now. Key Strategic Insights The most important takeaway from the earnings and the shareholder letter, in my opinion, is that Nebius is preparing for where AI is going next, not where it is today. Over the last year, the market has focused almost entirely on training infrastructure. Nebius is now aggressively positioning around inference and production AI deployment. NBIS acquisitions (Investor slides) The acquisition of Eigen AI strengthens Nebius Token Factory and improves inference execution and model...
Microsoft Corp.’s LinkedIn is cutting workers in the tech industry’s latest move to reduce headcount in the AI age. The professional social network must deliver increased impact to users and operate more profitably, LinkedIn Chief Executive Officer Daniel Shapero told employees in a memo on Wednesday. The reductions will impact a range of job functions, including engineering, product and marketing...
Microsoft Corp.’s LinkedIn is cutting workers in the tech industry’s latest move to reduce headcount in the AI age. The professional social network must deliver increased impact to users and operate more profitably, LinkedIn Chief Executive Officer Daniel Shapero told employees in a memo on Wednesday. The reductions will impact a range of job functions, including engineering, product and marketing, he wrote. “As part of our regular business planning, we’ve implemented organizational changes to best position ourselves for future success,” a company spokesperson said. Microsoft has been steadily paring jobs in recent years amid a margin-straining build-out of data centers and other infrastructure for its artificial intelligence services. The full scope of reductions couldn’t be determined. The division has 17,500 employees , according to its site. Read more: Microsoft Offers Buyouts to About 7% of US Workers Acquired in 2016, LinkedIn has largely operated independently from the rest of the company. It reported $17.8 billion in revenue in Microsoft’s most recent fiscal year, which ended in May 2025. The division is overseen by Executive Vice President Ryan Roslansky , who also watches over Microsoft’s office software. Shapero, who has been an executive at the company since before the acquisition, was named LinkedIn’s chief last month .
(Bloomberg) -- President Donald Trump arrived in Beijing for the first state visit to China by a US leader in nine years, as the world’s two largest economies look to stabilize ties with a summit playing out against the backdrop of the Iran war.Most Read from BloombergAmbani’s Cola War With Coke, Pepsi Spurs Fridge Bonanza in IndiaNvidia’s CEO Joins Trump in China With AI in the SpotlightMamdani S...
(Bloomberg) -- President Donald Trump arrived in Beijing for the first state visit to China by a US leader in nine years, as the world’s two largest economies look to stabilize ties with a summit playing out against the backdrop of the Iran war.Most Read from BloombergAmbani’s Cola War With Coke, Pepsi Spurs Fridge Bonanza in IndiaNvidia’s CEO Joins Trump in China With AI in the SpotlightMamdani Scraps Property Tax Hike, Counts Second-Home RevenueInside a Year of Chaos and Conflict at Kevin Hart
Blue Origin is weighing its first external fundraising as part of a push by Jeff Bezos’ rocket venture to hit ambitious launch targets and tap investor appetite boosted by SpaceX’s upcoming initial public offering. Chief Executive Dave Limp told employees at a recent all-hands meeting that the company would require outside investment if it were to significantly increase its launch cadence, accordi...
Blue Origin is weighing its first external fundraising as part of a push by Jeff Bezos’ rocket venture to hit ambitious launch targets and tap investor appetite boosted by SpaceX’s upcoming initial public offering. Chief Executive Dave Limp told employees at a recent all-hands meeting that the company would require outside investment if it were to significantly increase its launch cadence, according to details of the meeting from two people who attended. He said it would “take a lot of capital” to achieve the number of rocket launches Blue Origin has targeted—more money than would be available with “just one investor,” the people added. Read full article Comments
Iuliia Pilipeichenko/iStock via Getty Images When I covered Hims & Hers Health, Inc. ( HIMS ) back in February , my view was that the GLP-1 party was over and that the company had lost the growth engine that put it on investors' radars in the first place. The stock was in pullback mode, the SEC was investigating, and management hadn't yet shown me how the business defends itself without compounded...
Iuliia Pilipeichenko/iStock via Getty Images When I covered Hims & Hers Health, Inc. ( HIMS ) back in February , my view was that the GLP-1 party was over and that the company had lost the growth engine that put it on investors' radars in the first place. The stock was in pullback mode, the SEC was investigating, and management hadn't yet shown me how the business defends itself without compounded weight-loss drugs as the lead. Six weeks of Wegovy shipments later, I’m reassessing my sell. The company reported 1Q26 earnings on Monday after the bell, and the stock shot down over 14% on Tuesday and is flat on Wednesday as investors price in the double miss. Seeking Alpha HIMS reported a GAAP EPS loss of $0.40, missing consensus by $0.43, and revenue of $608 million also came in $8.75 million below consensus. In its first quarter selling Novo Nordisk's ( NVO ) branded GLP-1 directly through the platform, HIMS fulfilled more than 125,000 Wegovy shipments. Management is now guiding to 100,000+ monthly weight-loss subscriber adds going forward, which tells me that the branded transition I was skeptical about is running faster than I or the market expected. The Techie While I do think the market will have more digesting to do, I think that the stock is entering attractive territory, especially with more visibility on the weight loss growth driver. With the stock now testing the EMA50 support at $25, I think that as long as the stock holds above it, an entry at this level is favorable. On the weekly chart, the EMA200 support is also at $25, so again, if it breaks below that level, I wouldn’t be surprised with a pullback towards the next monthly support on the EMA200 at $14.5. You might be asking the question: Why did I give the stock a sell at $15.8 and upgrade to a buy at around $25? The Wegovy ramp The hardest part of writing a sell in February was that I had to assume the branded transition would be slower and messier than management implied. Compounded GLP-1 was where HI...
Shares of Personalis ( PSNL ) added ~11% on Wednesday after the Centers for Medicare & Medicaid Services expanded coverage for the cancer test maker’s NeXT Personal minimal residual disease test. The decision by CMS’s Molecular Diagnostic Services Program allows Medicare beneficiaries with late-stage solid tumors undergoing cancer immunotherapy to receive coverage for NeXT Personal for monitoring ...
Shares of Personalis ( PSNL ) added ~11% on Wednesday after the Centers for Medicare & Medicaid Services expanded coverage for the cancer test maker’s NeXT Personal minimal residual disease test. The decision by CMS’s Molecular Diagnostic Services Program allows Medicare beneficiaries with late-stage solid tumors undergoing cancer immunotherapy to receive coverage for NeXT Personal for monitoring their treatment response. "This decision validates our strategy of moving NeXT Personal into the heart of active treatment management,” Personalis ( PSNL ) CEO Chris Hall remarked. Several hundred thousand Americans are estimated to receive immunotherapy annually. However, the extent of their treatment response varies, making it critical for healthcare providers to identify which patients are responding to the therapy. "This coverage gives physicians another tool for proactively managing immunotherapy,” medical chief Richard Chen added. More on Personalis Personalis, Inc. (PSNL) Q1 2026 Earnings Call Transcript Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript Personalis outlines 2026 clinical volume target of 43,000 to 45,000 tests while reaffirming $78M to $80M revenue guidance Personalis GAAP EPS of -$0.29 misses by $0.02, revenue of $15.5M beats by $1.02M Seeking Alpha’s Quant Rating on Personalis
JHVEPhoto/iStock Editorial via Getty Images Elevator Thesis The debate about Micron Technology ( MU ) now focuses on whether AI has actually altered the way the memory industry operates. The rerating has been massive since my previous piece . The stock is now worth around $795 after a fiscal Q2 that was anything but a normal memory cycle. For some color, Q2 revenue, gross margin (non-GAAP) and EPS...
JHVEPhoto/iStock Editorial via Getty Images Elevator Thesis The debate about Micron Technology ( MU ) now focuses on whether AI has actually altered the way the memory industry operates. The rerating has been massive since my previous piece . The stock is now worth around $795 after a fiscal Q2 that was anything but a normal memory cycle. For some color, Q2 revenue, gross margin (non-GAAP) and EPS clocked in at $23.86 billion, 74.9% and $12.2, respectively. In addition, Q3 guidance suggests that revenues will be around $33.5 billion, while gross margins will be approximately 81%. The numbers are a sign of sustained pricing power in a segment that actually struggled to maintain it. Interestingly, my last piece on Micron focused on four key areas. First, AI is increasing the memory demand so swiftly that efficiency improvements would not be able to reduce it. Second, the demand for HBM would remain strong. Third, supply would fall behind growth in AI. Last but not least, earnings would keep coming in stronger than expected. So far, this framework has mostly remained intact. In reality, HBM and data center exposure have brought in record results. In fact, HBM capacity is effectively sold out through 2026 with visibility into 2027. That said, a greater change in substance has been the extent of tightness. Previous strength has been primarily in HBM. It's now going into DRAM, enterprise SSD and pricing. The shift is important since the shortage is becoming cross-border. It's starting to be a supply constraint throughout the market. That's why a follow-up is needed. The hyperscalers are no longer just opportunistic spot buyers as memory is increasingly becoming a more compact part of the AI infrastructure. Considering it all, MU stock remains a ‘Buy’ for me. To be honest, Micron is not priced on its traditional value around 13x forward non-GAAP earnings, with the consensus earnings estimate of $58 per share in FY26. However, it is also not priced like a structurally const...
JHVEPhoto/iStock Editorial via Getty Images Elevator Thesis The debate about Micron Technology ( MU ) now focuses on whether AI has actually altered the way the memory industry operates. The rerating has been massive since my previous piece . The stock is now worth around $795 after a fiscal Q2 that was anything but a normal memory cycle. For some color, Q2 revenue, gross margin (non-GAAP) and EPS...
JHVEPhoto/iStock Editorial via Getty Images Elevator Thesis The debate about Micron Technology ( MU ) now focuses on whether AI has actually altered the way the memory industry operates. The rerating has been massive since my previous piece . The stock is now worth around $795 after a fiscal Q2 that was anything but a normal memory cycle. For some color, Q2 revenue, gross margin (non-GAAP) and EPS clocked in at $23.86 billion, 74.9% and $12.2, respectively. In addition, Q3 guidance suggests that revenues will be around $33.5 billion, while gross margins will be approximately 81%. The numbers are a sign of sustained pricing power in a segment that actually struggled to maintain it. Interestingly, my last piece on Micron focused on four key areas. First, AI is increasing the memory demand so swiftly that efficiency improvements would not be able to reduce it. Second, the demand for HBM would remain strong. Third, supply would fall behind growth in AI. Last but not least, earnings would keep coming in stronger than expected. So far, this framework has mostly remained intact. In reality, HBM and data center exposure have brought in record results. In fact, HBM capacity is effectively sold out through 2026 with visibility into 2027. That said, a greater change in substance has been the extent of tightness. Previous strength has been primarily in HBM. It's now going into DRAM, enterprise SSD and pricing. The shift is important since the shortage is becoming cross-border. It's starting to be a supply constraint throughout the market. That's why a follow-up is needed. The hyperscalers are no longer just opportunistic spot buyers as memory is increasingly becoming a more compact part of the AI infrastructure. Considering it all, MU stock remains a ‘Buy’ for me. To be honest, Micron is not priced on its traditional value around 13x forward non-GAAP earnings, with the consensus earnings estimate of $58 per share in FY26. However, it is also not priced like a structurally const...
Sign up now! Sign up now! Sign up now? Sign up now! While the FA’s Independent Disciplinary Commission’s investigation into the Southampton spying scandal is likely to be scrupulously impartial, Football Daily couldn’t help but wonder if assorted EFL blazers might have been pogoing in celebration to the post-punk stylings of Middlesbrough anthem Papa’s Got a Brand New Pigbag when Riley McGree fire...
Sign up now! Sign up now! Sign up now? Sign up now! While the FA’s Independent Disciplinary Commission’s investigation into the Southampton spying scandal is likely to be scrupulously impartial, Football Daily couldn’t help but wonder if assorted EFL blazers might have been pogoing in celebration to the post-punk stylings of Middlesbrough anthem Papa’s Got a Brand New Pigbag when Riley McGree fired his club in front at St Mary’s on Tuesday night. Unwittingly embroiled in an administrative mess that could scarcely be more absurd or ridiculous, a Boro win would have gone a long way towards helping the EFL temporarily sweep spygate under the rug. As luck would have it, Southampton came back to win the tie , so the options of just hitting them with a whacking great fine and/or points deduction should they be found guilty of espionage are no longer the only ones on the table. As things stand, Tonda Eckert’s team are off to play Hull City in a Wembley playoff final worth a gazillion pounds, but if Football Daily was Robbie Mustoe, Phil Stamp or any other Middlesbrough player, we wouldn’t be jetting off on our summer holidays just yet. Rochdale fans will no doubt be breathing a sigh of relief that Slavia Prague’s ultras (yesterday’s Football Daily breakout section, full email edition) have pinched their most ill-advised pitch invasion of the season award” – Jim Hearson. The soccer cards aren’t in ‘very random places’ (yesterday’s Memory Lane, full email edition), they’re ordered by players’ surnames. Be disappointing if 1,056 others have pointed this out! The cards also include several players who didn’t actually make the squad and one, Paul Madeley, who turned a place down” – lan Burgess (and, oh yes, 1,056 others). What does ‘ jib off ’ mean?” – John Leftwich. This is an extract from our daily football email … Football Daily. To get the full version, just visit this page and follow the instructions . Continue reading...
shansekala/iStock via Getty Images Many fertilizer and chemical stocks in the Materials sector have scored solid gains as the conflict in Iran presses on. But not all are winners. ICL Group ( ICL ) remains far below its 2022 record high, with shares now trading at about half its peak price from four years ago. Indeed, the geopolitical and environmental setup has not been as bullish for the now $9 ...
shansekala/iStock via Getty Images Many fertilizer and chemical stocks in the Materials sector have scored solid gains as the conflict in Iran presses on. But not all are winners. ICL Group ( ICL ) remains far below its 2022 record high, with shares now trading at about half its peak price from four years ago. Indeed, the geopolitical and environmental setup has not been as bullish for the now $9 billion market cap stock. But ICL traded up 6% in early trading on Wednesday, May 13. The Israel-based company reported decent first-quarter numbers. I had a "B uy" rating on the stock in December 2023 . Shares are up 38% since then, lagging the S&P 500’s 61% advance. Today, I am downgrading ICL to a "H old." The valuation appears fair, given growth prospects, while the chart is mixed heading into mid-year. ICL Lags the Materials Sector & SPY YoY, But Off the Lows StockCharts.com In May, ICL reported a solid set of quarterly results. Q1 non-GAAP EPS of $0.11 topped the Wall Street consensus forecast by a penny, while revenue of $2.0 billion, up 14% from the same period a year earlier, pleased the street. Adjusted EBITDA jumped 15% YoY, and the management team hiked its guidance for the balance of the year. Shares jumped 5.8% in the hours after the numbers crossed the wires. The average post-earnings swing is 3.8%, according to data from Option Research & Technology Services, so today’s rally is notable. Implied volatility on ICL stock was 44% leading into the Q1 report, and if the gain holds to the close, it would mark the best earnings reaction since November 2024. Looking back on the quarter that was, ICL delivered a strong start to the year, with $2.0 billion in total sales, a 14% increase compared to the same period in 2025. There was ample growth down the income statement, including a 26% rise in adjusted net income to $139 million, a 15% jump in adjusted EBITDA to $412 million, and a 22% improvement in adjusted diluted EPS. The company appeared to execute well and nav...